ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms

April 8, 2011

DRCCA Organization Still Not Complete; Division Will Chemoprevention

October 3, 1980

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002